Point72 Hong Kong LTD Charles River Laboratories International, Inc. Transaction History

Point72 Hong Kong LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $2.88 Million - $4.26 Million	14,089 Added 615.78%	16,377 $3.5 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $388,630 - $550,769	1,521 Added 198.31%	2,288 $650,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $181,312 - $231,518	516 Added 205.58%	767 $289,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $93,532 - $115,033	251 New	251 $104,000
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $1.01 Million - $1.3 Million	-5,735 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $681,547 - $1.09 Million	5,735 New	5,735 $1 Million
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $192,459 - $347,049	-1,946 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $245,293 - $297,270	1,946 New	1,946 $297,000
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $116,815 - $134,187	-934 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $115,255 - $138,745	934 New	934 $133,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.